Investigation of DNA Repair and the Epigenome in Chemoresistant High-Grade Serous Ovarian Cancer

被引:0
作者
Wong-Brown, Michelle W. [1 ,2 ,3 ,4 ,5 ]
Lombard, Janine [6 ]
van der Westhuizen, Andre [6 ,7 ]
Bowden, Nikola A. [2 ,3 ,4 ,5 ,7 ]
机构
[1] Univ Newcastle, Fac Hlth, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia
[2] Univ Newcastle, Ctr Human Drug Res, Callaghan, NSW, Australia
[3] Univ Newcastle, Fac Hlth & Med, Prior Res Ctr Drug Dev, Callaghan, NSW, Australia
[4] Univ Newcastle, Fac Hlth & Med, Prior Res Ctr Canc Res Innovat & Translat, Callaghan, NSW, Australia
[5] Hunter Med Res Inst, Canc Res Program, New Lambton Hts, NSW, Australia
[6] Calvary Mater Newcastle, Waratah, NSW, Australia
[7] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Callaghan, NSW, Australia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PP21
引用
收藏
页码:29 / 30
页数:2
相关论文
共 50 条
  • [21] Evolution of platinum resistance in high-grade serous ovarian cancer
    Cooke, Susanna L.
    Brenton, James D.
    LANCET ONCOLOGY, 2011, 12 (12) : 1169 - 1174
  • [22] Tumor immunogenicity status in high-grade serous ovarian cancer
    Berry, Laurel
    Kelly, Michael
    Miller, Lance
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S319 - S319
  • [23] Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer
    Freimund, Alison E.
    Beach, Jessica A.
    Christie, Elizabeth L.
    Bowtell, David D. L.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (06) : 983 - +
  • [24] Determinants of resistance and response in high-grade serous ovarian cancer
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2016, 22
  • [25] Novel strategies for targeting high-grade serous ovarian cancer
    Perets, Ruth
    Wyant, Gregory A.
    Ohman, Anders W.
    Setlur, Sunita R.
    Crum, Christopher P.
    Drapkin, Ronny
    Dinulescu, Daniela M.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [26] Describing intratumoural heterogeneity in high-grade serous ovarian cancer
    Nixon, K.
    Wulandari, R.
    Curry, E.
    Rama, N.
    Bowtell, D.
    Cunnea, P.
    Fotopoulou, C.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 87 - 88
  • [27] Defining the Molecular Footsteps of High-Grade Serous Ovarian Cancer
    Nagendra, P.
    Lombard, J.
    Jamaluddin, F.
    Tanwar, P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 26 - 26
  • [28] Principles of dormancy evident in high-grade serous ovarian cancer
    Shepherd, Trevor G.
    Dick, Frederick A.
    CELL DIVISION, 2022, 17 (01)
  • [29] Centrosomes - The Achilles' heel of high-grade serous ovarian cancer?
    Chandrasekaran, G.
    Hall, D.
    Vias, M.
    Brenton, J. D.
    Gergely, F.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [30] The peritoneal tumour microenvironment of high-grade serous ovarian cancer
    Leinster, D. Andrew
    Kulbe, Hagen
    Everitt, Gemma
    Thompson, Richard
    Perretti, Mauro
    Gavins, Felicity N. E.
    Cooper, Dianne
    Gould, David
    Ennis, Darren P.
    Lockley, Michelle
    McNeish, Iain A.
    Nourshargh, Sussan
    Balkwill, Frances R.
    JOURNAL OF PATHOLOGY, 2012, 227 (02) : 136 - 145